Rock Springs Capital Management LP - Significant Ownership

Signature - Title
/s/ Mark Bussard - Mark Bussard - Member
Location
Baltimore, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Rock Springs Capital Management LP.

Significant Ownership of Rock Springs Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TLPH TALPHERA, INC. Common Stock, $0.001 par value 7.88% $1.87M 3.59M Rock Springs Capital Management LP Sep 10, 2025
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 4.7% $7.72M 5.05M Rock Springs Capital Management LP Mar 31, 2025
MREO MEREO BIOPHARMA GROUP PLC Ordinary Shares, nominal value 0.003, per ordinary share 4.2% $65.2M 33.4M Rock Springs Capital Management LP Mar 31, 2025
TVTX Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $39.4M -$27.7M 2.92M -41.3% Rock Springs Capital Management LP Mar 31, 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP Mar 31, 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP Jul 3, 2025
INZY Inozyme Pharma, Inc. Common stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP Jun 30, 2025

Schedules 13D/G Reported by Rock Springs Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.